National Influenza Vaccine Task Force

The National Influenza Vaccine Task Force is an American federal government task force created by President Donald Trump composed of many government agencies and representatives.

History

On September 19, 2019, United States President Donald Trump issued Executive Order (EO) 13887: Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health.1) The primary action of the EO was to create a National Influenza Vaccine Task Force in anticipation of an upcoming pandemic, focusing on ramping up “innovative, faster, and more scaleable technologies” than was previously used for influenza vaccines.

It additionally called for development and strengthening of public-private partnerships, including the transfer of technology to such partnerships, specifically mentioning the HHS Centers for Innovation in Advanced Development and Manufacturing. Shortly after, in December 2019, the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna signed an agreement to transfer their jointly-owned mRNA vaccine candidates to the University of North Carolina at Chapel Hill.2)

In August 2020, the task force published a report titled National Influenza Vaccine Modernization Strategy 2020-2030.3)

Organization

Members

1)
Trump, D. J. (2019, September 19). Executive Order on Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health. The White House. https://archive.ph/5j8Zo
2)
Secret Docs Reveal Moderna Sent Coronavirus Vaccine To North Carolina University Weeks Before Pandemic. (2021, June 20). GreatGameIndia. https://web.archive.org/web/20220531014844/https://greatgameindia.com/moderna-vaccine-north-carolina-university/
3)
National Influenza Vaccine Task Force. (2020, August 28). National Influenza Vaccine Modernization Strategy 2020-2030. Office of the Assistant Secretary for Preparedness and Response. https://archive.ph/L2I4o
Back to top